You are here: Home:  NHLU 6 2005 : Craig Moskowitz, MD: Select publications


SELECT PUBLICATIONS

Coiffier B et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002;346(4):235-42. Abstract

Halaas JL et al. R-CHOP-14 in patients with diffuse large B-cell lymphoma: Feasibility and preliminary efficacy. Leuk Lymphoma 2005;46(4):541-7. Abstract

Hans CP et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004;103(1):275- 82. Abstract

Kewalramani T et al. Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma. Blood 2004;103(10):3684-8. Abstract

Moskowitz CH et al. Cell of origin, germinal center versus nongerminal center, determined by immunohistochemistry on tissue microarray, does not correlate with outcome in patients with relapsed and refractory DLBCL. Blood 2005;106(10):3383-5. Abstract

Norton L, Simon R. The Norton-Simon Hypothesis revisited. Cancer Treat Rep 1986;70(1):163-9. No abstract available

Pfreundschuh M et al; German High-Grade Non-Hodgkin’s Lymphoma Study. Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: Results of the NHL-B2 trial of the DSHNHL. Blood 2004;104(3):634-41. Abstract

Portlock CS et al. The NHL-15 protocol for aggressive non-Hodgkin’s lymphomas: A sequential dose-dense, dose-intense regimen of doxorubicin, vincristine and high-dose cyclophosphamide. Ann Oncol 2004;15(10):1495-503. Abstract

 

Table of Contents Top of Page

Table of Contents
 
Editor’s Note:
R-CHOP Cowboy
 
Craig Moskowitz, MD
- Select publications
 
Wyndham H Wilson, MD, PhD
- Select publications
 
Anas Younes, MD
- Select publications
 
A CME Audio Series
and Activity
Faculty Disclosures
Editor's office